Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-22-018821 General Corporate
Debt relative to revenue 39th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
122.44% · OPTIONAL · VALID
Capex intensity 6th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.75% · OPTIONAL · VALID
Operating cash generation 11th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.92% · OPTIONAL · VALID
Revenue growth 79th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
29.69% · CORE · VALID
Inventory pressure 56th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
57.97% · OPTIONAL · VALID
Gross margin 44th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
21.25% · CORE · VALID
Operating margin 89th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
14.74% · CORE · VALID
R&D intensity 0th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.28% · OPTIONAL · VALID
SBC intensity 33th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.46% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 135.64%
Current 122.44%
Delta -13.20% Capex Intensity Increased
Previous 3.10%
Current 3.75%
Delta 0.66% Cash Generation Increased
Previous -5.06%
Current 0.92%
Delta 5.98% Growth Decreased
Previous 29.76%
Current 29.69%
Delta -0.07% Inventory Pressure Increased
Previous 56.40%
Current 57.97%
Delta 1.56% Margin Increased
Previous 20.45%
Current 21.25%
Delta 0.79% Profitability Increased
Previous -8.57%
Current 14.74%
Delta 23.32% R And D Intensity Decreased
Previous 1.34%
Current 1.28%
Delta -0.06% Sbc Intensity Decreased
Previous 0.62%
Current 0.46%
Delta -0.16% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.